• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用快速可重现交联质谱技术对人白细胞抗原上同种异体抗体结合的混合结构建模。

Hybrid structural modeling of alloantibody binding to human leukocyte antigen with rapid and reproducible cross-linking mass spectrometry.

机构信息

Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.

Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117545, Singapore; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117545, Singapore.

出版信息

Cell Rep Methods. 2023 Sep 25;3(9):100569. doi: 10.1016/j.crmeth.2023.100569. Epub 2023 Aug 30.

DOI:10.1016/j.crmeth.2023.100569
PMID:37751693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10545907/
Abstract

Alloantibody recognition of donor human leukocyte antigen (HLA) is associated with poor clinical transplantation outcomes. However, the molecular and structural basis for the alloantibody-HLA interaction is not well understood. Here, we used a hybrid structural modeling approach on a previously studied alloantibody-HLA interacting pair with inputs from ab initio, in silico, and in vitro data. Highly reproducible cross-linking mass spectrometry data were obtained with both discovery- and targeted mass spectrometry-based approaches approaches. The cross-link information was then used together with predicted antibody F structure, predicted antibody paratope, and in silico-predicted interacting surface to model the antibody-HLA interaction. This hybrid structural modeling approach closely recapitulates the key interacting residues from a previously solved crystal structure of an alloantibody-HLA-A∗11:01 pair. These results suggest that a predictive-based hybrid structural modeling approach supplemented with cross-linking mass spectrometry data can provide functionally relevant structural models to understand the structural basis of antibody-HLA mismatch in transplantation.

摘要

同种异体抗体对供体人类白细胞抗原 (HLA) 的识别与不良的临床移植结果相关。然而,同种异体抗体-HLA 相互作用的分子和结构基础尚未得到很好的理解。在这里,我们使用了一种混合结构建模方法,该方法使用了从头计算、计算机模拟和体外数据作为输入,对先前研究过的同种异体抗体-HLA 相互作用对进行了研究。使用基于发现和靶向质谱的方法获得了高度可重现的交联质谱数据。然后,将交联信息与预测的抗体 F 结构、预测的抗体结合位和计算机预测的相互作用表面一起用于构建抗体-HLA 相互作用模型。这种混合结构建模方法紧密地再现了之前解决的同种异体抗体-HLA-A∗11:01 对晶体结构的关键相互作用残基。这些结果表明,基于预测的混合结构建模方法结合交联质谱数据,可以提供功能相关的结构模型,以了解移植中抗体-HLA 不匹配的结构基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/2a5583e1d48d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/b218150b310d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/b4ae9e841373/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/d5acd3a65b63/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/d64f61536103/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/2a5583e1d48d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/b218150b310d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/b4ae9e841373/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/d5acd3a65b63/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/d64f61536103/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd4f/10545907/2a5583e1d48d/gr4.jpg

相似文献

1
Hybrid structural modeling of alloantibody binding to human leukocyte antigen with rapid and reproducible cross-linking mass spectrometry.利用快速可重现交联质谱技术对人白细胞抗原上同种异体抗体结合的混合结构建模。
Cell Rep Methods. 2023 Sep 25;3(9):100569. doi: 10.1016/j.crmeth.2023.100569. Epub 2023 Aug 30.
2
Protocol for structural modeling of antibody to human leukocyte antigen interaction using discovery and targeted cross-linking mass spectrometry.采用发现和靶向交联质谱法对人白细胞抗原抗体相互作用进行结构建模的方案。
STAR Protoc. 2024 Mar 15;5(1):102927. doi: 10.1016/j.xpro.2024.102927. Epub 2024 Mar 2.
3
Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01.定义人类白细胞抗原等位基因 HLA-A*11:01 与人源抗体结合的结构基础。
Nat Commun. 2019 Feb 21;10(1):893. doi: 10.1038/s41467-019-08790-1.
4
Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.主动脉瓣同种异体移植物结构恶化与一部分针对人类白细胞抗原的抗体有关。
J Heart Valve Dis. 2003 May;12(3):382-90; discussion 390-1.
5
Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.从氨基酸多态性的数量和理化性质预测HLA I类同种抗原免疫原性
Transplantation. 2009 Sep 27;88(6):791-8. doi: 10.1097/TP.0b013e3181b4a9ff.
6
High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes.高分辨率、三维建模的人类白细胞抗原 I 类结构和表面静电势揭示了同种异体抗体结合表位的分子基础。
Hum Immunol. 2011 Nov;72(11):1049-59. doi: 10.1016/j.humimm.2011.07.303. Epub 2011 Jul 28.
7
Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.从氨基酸多态性的数量和物理化学性质预测 HLA Ⅱ类同种抗原免疫原性。
Transplantation. 2011 Jan 27;91(2):183-90. doi: 10.1097/TP.0b013e3181ffff99.
8
IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.大鼠肾移植排斥反应后针对MHC I类和II类分子的IgM和IgG同种抗体反应。移植肾切除术和移植后输血的影响。
Transplantation. 1992 Jan;53(1):167-74. doi: 10.1097/00007890-199201000-00034.
9
Microfluidic antibody affinity profiling of alloantibody-HLA interactions in human serum.人血清中同种抗体与 HLA 相互作用的微流控抗体亲和力分析
Biosens Bioelectron. 2023 May 15;228:115196. doi: 10.1016/j.bios.2023.115196. Epub 2023 Mar 5.
10
HLA and lung transplantation.HLA 与肺移植。
Front Med. 2019 Jun;13(3):298-313. doi: 10.1007/s11684-018-0636-x. Epub 2019 Jun 11.

引用本文的文献

1
Occlusion of TCR binding to HLA-A*11:01 by a non-pathogenic human alloantibody.一种非致病性人类同种异体抗体对TCR与HLA - A*11:01结合的阻断作用。
Cell Mol Life Sci. 2025 Feb 26;82(1):94. doi: 10.1007/s00018-025-05614-y.

本文引用的文献

1
Cross-linking mass spectrometry discovers, evaluates, and corroborates structures and protein-protein interactions in the human cell.交联质谱技术可用于发现、评估和验证人类细胞中的结构和蛋白质-蛋白质相互作用。
Proc Natl Acad Sci U S A. 2023 Apr 25;120(17):e2219418120. doi: 10.1073/pnas.2219418120. Epub 2023 Apr 18.
2
Protein structure predictions to atomic accuracy with AlphaFold.使用AlphaFold进行原子精度的蛋白质结构预测。
Nat Methods. 2022 Jan;19(1):11-12. doi: 10.1038/s41592-021-01362-6.
3
Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2.
靶向原位交联质谱和整合建模揭示了来自新型冠状病毒的三种蛋白质的结构。
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2103554118.
4
Extracellular crosslinking mass spectrometry reveals HLA class I - HLA class II interactions on the cell surface.细胞外交联质谱法揭示细胞表面 HLA Ⅰ类分子 - HLA Ⅱ类分子相互作用。
Mol Immunol. 2021 Aug;136:16-25. doi: 10.1016/j.molimm.2021.05.010. Epub 2021 May 27.
5
From integrative structural biology to cell biology.从整合结构生物学到细胞生物学。
J Biol Chem. 2021 Jan-Jun;296:100743. doi: 10.1016/j.jbc.2021.100743. Epub 2021 May 4.
6
Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.利用 Rosetta 进行免疫建模:抗体和抗原设计方法。
Biochemistry. 2021 Mar 23;60(11):825-846. doi: 10.1021/acs.biochem.0c00912. Epub 2021 Mar 11.
7
Defining the structural basis for human leukocyte antigen reactivity in clinical transplantation.定义临床移植中人类白细胞抗原反应的结构基础。
Sci Rep. 2020 Oct 27;10(1):18397. doi: 10.1038/s41598-020-75355-4.
8
Epitope and Paratope Mapping of PD-1/Nivolumab by Mass Spectrometry-Based Hydrogen-Deuterium Exchange, Cross-linking, and Molecular Docking.基于氢氘交换、交联和分子对接的质谱技术分析 PD-1/纳武利尤单抗的表位和变构位
Anal Chem. 2020 Jul 7;92(13):9086-9094. doi: 10.1021/acs.analchem.0c01291. Epub 2020 Jun 10.
9
Development of R7BP inhibitors through cross-linking coupled mass spectrometry and integrated modeling.通过交联偶联质谱和集成建模开发 R7BP 抑制剂。
Commun Biol. 2019 Sep 13;2:338. doi: 10.1038/s42003-019-0585-1. eCollection 2019.
10
Optimized Cross-Linking Mass Spectrometry for in Situ Interaction Proteomics.优化交联质谱法用于原位相互作用蛋白质组学。
J Proteome Res. 2019 Jun 7;18(6):2545-2558. doi: 10.1021/acs.jproteome.9b00085. Epub 2019 May 24.